Cero Therapeutics Hldgs Inc.
13F holders, Q1 2024 (March 31)9holders
$2.91avg. 13F price*
At the end of Q1 2024, 9 institutions reported holding Cero Therapeutics Hldgs Inc. in their 13F filings. The largest holders were ARCH Venture Management, LLC ($4.4M), HSG Holding Ltd ($202K) and Jane Street Group, LLC ($81K).
- Company
- Cero Therapeutics Hldgs Inc.
- CUSIP
- 71902K105
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $4.8M |
| Exits | 9 | $7.4M |
Ownership 9 holders
| ARCH Venture Management, LLC | 5.52% | New | 1,444,296 | $4.4M |
| HSG Holding Ltd | 0.02% | New | 149,999 | $202K |
| Jane Street Group, LLC | 0.00% | New | 26,515 | $81K |
| Birchview Capital, LP | 0.03% | New | 12,972 | $40K |
| Geode Capital Management, LLC | 0.00% | No change | 10,588 | $33K |
| FNY Investment Advisers, LLC | 0.02% | New | 10,500 | $32K |
| Kestra Private Wealth Services, LLC | 0.00% | New | 10,000 | $31K |
| Pineridge Advisors LLC | 0.00% | New | 300 | $921 |
| JPMorgan Chase & Co. | 0.00% | New | 2 | $6 |
"% of holder's portfolio" is CERO THERAPEUTICS HLDGS INC's weight in each manager's 13F, not the share of Cero Therapeutics Hldgs Inc. the manager owns.